Business Context and Reporting Period
Oragenics, Inc. filed a Form 8-K Current Report dated June 30, 2016. The filing discloses the entry into a Material Definitive Agreement involving the issuance and sale of restricted common stock to three accredited investors.
Key Financial Metrics
- Transaction Type: Private placement of restricted common stock.
- Shares Issued: 9,045,679 shares.
- Purchase Price: $0.5159 per share (midpoint of closing quote on June 29, 2016).
- Gross Proceeds: Approximately $4.667 million.
- Payment Structure: $2 million payable via an unsecured promissory note due September 30, 2016; the remaining balance paid immediately.
- Note Terms: Unsecured, bearing interest at 3% per annum.
- Transaction Costs: No brokerage or finder's fees were paid.
Material Changes
The filing reports a significant capital raise event rather than operational performance changes. The Company's capital structure was altered by the issuance of over 9 million new shares. The transaction included current shareholders (Koski Family Limited Partnership and Intrexon Corporation) and the Company's Chairman, Dr. Frederick Telling.
Outlook, Risks, and Unusual Items
- Investor Rights: Investors were granted piggyback registration rights subject to customary exceptions.
- Regulatory Status: The offering was made in reliance on exemptions from registration under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
- Liquidity Impact: The transaction provides immediate and deferred cash inflows to the Company.
- Disclosure: A press release regarding this transaction was issued on June 30, 2016, under Regulation FD.
Investor Verification Checklist
- Verify the exact amount of cash received immediately versus the $2 million deferred via the promissory note.
- Confirm the dilution impact of 9,045,679 new shares on existing shareholders.
- Review the full text of the Stock Purchase Agreement (Exhibit 10.1) for specific covenants or restrictions.
- Check the Company's subsequent cash flow statements to confirm the receipt of the note payment on September 30, 2016.